2013
DOI: 10.1016/j.ijcard.2013.03.027
|View full text |Cite
|
Sign up to set email alerts
|

Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

7
93
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 118 publications
(100 citation statements)
references
References 37 publications
7
93
0
Order By: Relevance
“…We demonstrated that non-HDL cholesterol (including Diff-C fraction) is strongly associated with metabolic syndrome. It was a consistent finding after multiple adjustments, in line with the majority of previous studies [2226]. …”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…We demonstrated that non-HDL cholesterol (including Diff-C fraction) is strongly associated with metabolic syndrome. It was a consistent finding after multiple adjustments, in line with the majority of previous studies [2226]. …”
Section: Discussionsupporting
confidence: 91%
“…Plasma concentrations of the lipoproteins were highly related to the number of MetS components which was similar to results of previous studies [2224]. The prevalence of MetS increased to a large degree along with rising levels of total non-HDL-C and Diff-C fractions regardless of gender type or criteria set for MetS.…”
Section: Discussionsupporting
confidence: 88%
“…The NonHDLc/HDLc ratio captures atherogenic lipid abnormalities other than LDLc including abnormalities in lipid particles such as small dense LDL, very low-density lipoproteins (VLDL), and HDLc similarly to that of ApoB/A1 [9]. Accordingly, the NonHDLc/HDLc ratio had a stronger association with CHD risk than LDLc, HDL-cholesterol or non-HDL-cholesterol [11,20,21]. Our research described here extends findings that the NonHDLc/HDLc ratio not only is associated with CHD but also with the development of CKD.…”
Section: Discussionmentioning
confidence: 99%
“…identifying metabolic syndrome and insulin resistance [11]. Although sharing similar risk factors with CHD, little is known about the association between the NonHDLc/HDLc ratio and CKD.…”
Section: A C C E P T E D Accepted Manuscriptmentioning
confidence: 99%
“…The LDLC:HDLC ratio can predict CHD development with higher hazard ratio than LDLC and HDLC levels and has been found to be an independent predictor for acute myocardial infarction in the Japanese population [4,7]. The non-HDLC:HDLC ratio is also suggested to be a better predictor of CHD risk than LDLC levels in a follow-up study for a mean of 4.8 years in the Swedish National Diabetes Register and has been found to be a stronger marker of metabolic syndrome and insulin resistance in Korean adults than apolipoprotein B/apolipoprotein A1 [8,9]. …”
Section: Introductionmentioning
confidence: 99%